A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma
Clinical trial NCT00289016 · COMPLETED
Trial details
- NCT number
- NCT00289016
- Sponsor
- BioVex Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2008-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.